Medicare Advantage Denials: OIG Report Reveals Significant Barriers to Patient Care

A recent report from the U.S. Department of Health and Human Services (HHS) Office of Inspector General (OIG) reveals that Medicare Advantage plans frequently deny requests for critical services, such as inpatient rehabilitation and long-term acute care, at disproportionately high rates. The findings, released in 2024, indicate that some insurers reject prior authorization requests for these essential treatments up to 80% of the time, creating significant hurdles for patients recovering from strokes, heart conditions, and severe injuries.

Why Are Prior Authorization Denial Rates So High?

The OIG investigation, which analyzed data from 19 major Medicare Advantage organizations, suggests a systemic breakdown in the initial review process. According to the Office of Inspector General, when patients or providers appeal these initial rejections, plans reverse their decisions 95% of the time. This high overturn rate indicates that a large volume of care initially deemed “not medically necessary” by insurers is later identified as appropriate upon secondary review. The variation in denial rates is stark, ranging from 8% to 80% depending on the specific insurance company, a discrepancy that regulators described as unexpected.

How Do Denials Impact Patient Recovery?

Prior authorization is a cost-containment tool that requires providers to obtain approval from an insurer before performing specific services. When these requests are denied, patients often face delays in receiving life-altering care or are forced to pay out-of-pocket for services that would typically be covered under traditional Medicare. According to KFF, a nonpartisan health policy research organization, these rejections are particularly consequential for high-cost treatments. Inpatient rehabilitation facilities cost approximately $24,000 per stay, while long-term acute care hospitals average around $49,000, creating a financial incentive for private insurers to scrutinize these claims more aggressively than other medical services.

What Is the Government Doing About Insurance Oversight?

Federal regulators are now moving to increase transparency in the Medicare Advantage market. The OIG has recommended that the Centers for Medicare & Medicaid Services (CMS) implement more robust data collection regarding prior authorization. Currently, there is limited visibility into how different insurers manage these requests. While industry trade groups, such as AHIP, have stated that major health plans are working to streamline preapproval requirements—noting an 11% reduction in authorizations for certain services—the OIG report highlights that for-profit insurers continue to show higher denial rates compared to their nonprofit counterparts.

Key Data Points on Medicare Advantage Coverage

• High Overturn Rate: 95% of denied prior authorization requests for skilled nursing facility care were overturned upon appeal.
• Market Scope: Approximately 20 million Americans are enrolled in plans managed by the three companies identified as having the highest denial rates: UnitedHealthcare, CVS Health (Aetna), and Humana.
• Disparate Outcomes: For-profit insurers show a statistically higher likelihood of denying care compared to nonprofit entities, according to policy analysts.

Future Outlook for Medicare Reform

The path forward remains uncertain as the government balances the insurance industry’s argument that prior authorization prevents unnecessary costs with the documented evidence of patient-care delays. While some insurers, including UnitedHealthcare, have announced initiatives to remove specific authorization requirements for certain patient populations, experts note that the effectiveness of these reforms will take time to materialize. The OIG’s recommendation for ongoing investigation into the wide variation of denial rates suggests that federal oversight of these private-sector alternatives to traditional Medicare will likely intensify in the coming fiscal year.